Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.745 USD | -3.06% | -0.85% | +208.85% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+208.85% | 331M | |
+32.34% | 694B | |
+29.39% | 593B | |
-1.40% | 371B | |
+20.03% | 331B | |
+7.31% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.46% | 169B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- William Blair Downgrades Nektar Therapeutics to Market Perform Form Outperform, Adjusts Price Target to $4.49 From $10.98